The immune landscape of undifferentiated pleomorphic sarcoma.

Saved in:
Bibliographic Details
Title: The immune landscape of undifferentiated pleomorphic sarcoma.
Authors: Lazcano R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barreto CM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salazar R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Carapeto F; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Traweek RS; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Leung CH; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gite S; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mehta J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ingram DR; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wani KM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vu KT; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Parra ER; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lu W; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Zhou J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Witt RG; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cope B; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Thirasastr P; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lin HY; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Scally CP; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Conley AP; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ratan R; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Livingston JA; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Zarzour AM; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ludwig J; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Araujo D; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ravi V; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patel S; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Benjamin R; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wargo J; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wistuba II; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Somaiah N; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Roland CL; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Keung EZ; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Solis L; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang WL; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Lazar AJ; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nassif EF; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Source: Frontiers in oncology [Front Oncol] 2022 Oct 12; Vol. 12, pp. 1008484. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36313661
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The immune landscape of undifferentiated pleomorphic sarcoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lazcano+R%22">Lazcano R</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Barreto+CM%22">Barreto CM</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Salazar+R%22">Salazar R</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Carapeto+F%22">Carapeto F</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Traweek+RS%22">Traweek RS</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Leung+CH%22">Leung CH</searchLink>; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Gite+S%22">Gite S</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Mehta+J%22">Mehta J</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ingram+DR%22">Ingram DR</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wani+KM%22">Wani KM</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Vu+KT%22">Vu KT</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Parra+ER%22">Parra ER</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lu+W%22">Lu W</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Witt+RG%22">Witt RG</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Cope+B%22">Cope B</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Thirasastr+P%22">Thirasastr P</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lin+HY%22">Lin HY</searchLink>; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Scally+CP%22">Scally CP</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ratan+R%22">Ratan R</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Livingston+JA%22">Livingston JA</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Zarzour+AM%22">Zarzour AM</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ludwig+J%22">Ludwig J</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Araujo+D%22">Araujo D</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ravi+V%22">Ravi V</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Benjamin+R%22">Benjamin R</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wargo+J%22">Wargo J</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wistuba+II%22">Wistuba II</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Somaiah+N%22">Somaiah N</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Roland+CL%22">Roland CL</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Keung+EZ%22">Keung EZ</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Solis+L%22">Solis L</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Nassif+EF%22">Nassif EF</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Oct 12; Vol. 12, pp. 1008484. <i>Date of Electronic Publication: </i>2022 Oct 12 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36313661
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.1008484
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1008484
    Titles:
      – TitleFull: The immune landscape of undifferentiated pleomorphic sarcoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lazcano R
      – PersonEntity:
          Name:
            NameFull: Barreto CM
      – PersonEntity:
          Name:
            NameFull: Salazar R
      – PersonEntity:
          Name:
            NameFull: Carapeto F
      – PersonEntity:
          Name:
            NameFull: Traweek RS
      – PersonEntity:
          Name:
            NameFull: Leung CH
      – PersonEntity:
          Name:
            NameFull: Gite S
      – PersonEntity:
          Name:
            NameFull: Mehta J
      – PersonEntity:
          Name:
            NameFull: Ingram DR
      – PersonEntity:
          Name:
            NameFull: Wani KM
      – PersonEntity:
          Name:
            NameFull: Vu KT
      – PersonEntity:
          Name:
            NameFull: Parra ER
      – PersonEntity:
          Name:
            NameFull: Lu W
      – PersonEntity:
          Name:
            NameFull: Zhou J
      – PersonEntity:
          Name:
            NameFull: Witt RG
      – PersonEntity:
          Name:
            NameFull: Cope B
      – PersonEntity:
          Name:
            NameFull: Thirasastr P
      – PersonEntity:
          Name:
            NameFull: Lin HY
      – PersonEntity:
          Name:
            NameFull: Scally CP
      – PersonEntity:
          Name:
            NameFull: Conley AP
      – PersonEntity:
          Name:
            NameFull: Ratan R
      – PersonEntity:
          Name:
            NameFull: Livingston JA
      – PersonEntity:
          Name:
            NameFull: Zarzour AM
      – PersonEntity:
          Name:
            NameFull: Ludwig J
      – PersonEntity:
          Name:
            NameFull: Araujo D
      – PersonEntity:
          Name:
            NameFull: Ravi V
      – PersonEntity:
          Name:
            NameFull: Patel S
      – PersonEntity:
          Name:
            NameFull: Benjamin R
      – PersonEntity:
          Name:
            NameFull: Wargo J
      – PersonEntity:
          Name:
            NameFull: Wistuba II
      – PersonEntity:
          Name:
            NameFull: Somaiah N
      – PersonEntity:
          Name:
            NameFull: Roland CL
      – PersonEntity:
          Name:
            NameFull: Keung EZ
      – PersonEntity:
          Name:
            NameFull: Solis L
      – PersonEntity:
          Name:
            NameFull: Wang WL
      – PersonEntity:
          Name:
            NameFull: Lazar AJ
      – PersonEntity:
          Name:
            NameFull: Nassif EF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 10
              Text: 2022 Oct 12
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1